Private Advisor Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $113K | Sell |
|
|||||
|
2023
Q2 | $167K | Buy |
|
|||||
|
2023
Q1 | $147K | Sell |
|
|||||
|
2022
Q4 | $175 | Sell |
|
|||||
|
2022
Q3 | $222K | Sell |
|
|||||
|
2022
Q2 | $369K | Buy |
|
|||||
|
2022
Q1 | $404K | Buy |
|
|||||
|
2021
Q4 | $519K | Buy |
|
|||||
|
2021
Q3 | $620K | Hold |
|
|||||
|
2021
Q2 | $651K | Buy |
|
|||||
|
2021
Q1 | $596K | Sell |
|
|||||
|
2020
Q4 | $655K | Sell |
|
|||||
|
2020
Q3 | $584K | Buy |
|
|||||
|
2020
Q2 | $570K | Sell |
|
|||||
|
2020
Q1 | $474K | Buy |
|
|||||
|
2019
Q4 | $504K | Sell |
|
|||||
|
2019
Q3 | $417K | Buy |
|
|||||
|
2019
Q2 | $462K | Sell |
|
|||||
|
2019
Q1 | $507K | Buy |
|
|||||
|
2018
Q4 | $362K | Buy |
|
|||||
|
2018
Q3 | $376K | Buy |
|